Market Value333,932,000
Total Holdings60
File Date2020-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CHNG / Change Healthcare Inc
US7170711045 / Pfenex Inc.
EXEL / Exelixis, Inc.
INCY / Incyte Corporation
CCXI / ChemoCentryx Inc
UHS / Universal Health Services, Inc.
GWP / GW Pharmaceuticals plc
BSX / Boston Scientific Corporation
HALO / Halozyme Therapeutics, Inc.
MASI / Masimo Corporation
CHWY / Chewy, Inc.
LHCG / LHC Group Inc
NUVA / Nuvasive Inc
NERV / Minerva Neurosciences, Inc.
US3723091043 / GenMark Diagnostics, Inc
US60877T1007 / Momenta Pharmaceuticals, Inc.
ZGNX / Zogenix Inc
DRNA / Dicerna Pharmaceuticals Inc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
EXEL / Exelixis, Inc.
PODD / Insulet Corporation
TXG / 10x Genomics, Inc.
RVTY / Revvity, Inc.
MDT / Medtronic plc
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
CNC / Centene Corporation
FATE / Fate Therapeutics, Inc.
MRNA / Moderna, Inc. Put
ARVN / Arvinas, Inc.
ALKS / Alkermes plc
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
AKBA / Akebia Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
UNH / UnitedHealth Group Incorporated
CRL / Charles River Laboratories International, Inc.
ABT / Abbott Laboratories
HZNP / Horizon Therapeutics Plc
KPTI / Karyopharm Therapeutics Inc.
MOH / Molina Healthcare, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
NVST / Envista Holdings Corporation
ARNA / Arena Pharmaceuticals Inc
GOSS / Gossamer Bio, Inc.
AGIO / Agios Pharmaceuticals, Inc.
CTLT / Catalent, Inc.
SGEN / Seagen Inc
MRTX / Mirati Therapeutics, Inc.
DHR / Danaher Corporation
ZBH / Zimmer Biomet Holdings, Inc.
BDX / Becton, Dickinson and Company
DNLI / Denali Therapeutics Inc.
DGX / Quest Diagnostics Incorporated
NBIX / Neurocrine Biosciences, Inc.
EXAS / Exact Sciences Corporation
NVRO / Nevro Corp.
BMRN / BioMarin Pharmaceutical Inc.
PTCT / PTC Therapeutics, Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
REGN / Regeneron Pharmaceuticals, Inc.
WBA / Walgreens Boots Alliance, Inc.
SAGE / Sage Therapeutics, Inc.
COR / Cencora, Inc.
MGNX / MacroGenics, Inc.
ITCI / Intra-Cellular Therapies, Inc. Call
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
BAX / Baxter International Inc.
CYTK / Cytokinetics, Incorporated
XRAY / DENTSPLY SIRONA Inc.
ABBV / AbbVie Inc.
BMY / Bristol-Myers Squibb Company
DXCM / DexCom, Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
LLY / Eli Lilly and Company
EHC / Encompass Health Corporation
MCK / McKesson Corporation
BPMC / Blueprint Medicines Corporation
MRK / Merck & Co., Inc.
AMGN / Amgen Inc.
HUM / Humana Inc.
ISRG / Intuitive Surgical, Inc.